Literature DB >> 20098535

Effect of Ondansetron, a 5-HT(3) receptor antagonist, on fatigue in 2 veterans with hepatitis C.

Dimitre H Dimitrov1.   

Abstract

Entities:  

Year:  2009        PMID： 20098535      PMCID： PMC2805579          DOI： 10.4088/PCC.08l00755

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN： 1523-5998


× No keyword cloud information.
  8 in total

Review 1.  Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches.

Authors:  Gregory M Asnis; Richard De La Garza
Journal:  J Clin Gastroenterol       Date:  2006-04       Impact factor: 3.062

Review 2.  The effects of interferon-alpha on the production and action of other cytokines.

Authors:  J L Taylor; S E Grossberg
Journal:  Semin Oncol       Date:  1998-02       Impact factor: 4.929

3.  Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment.

Authors:  K Weissenborn; J C Ennen; M Bokemeyer; B Ahl; U Wurster; H Tillmann; C Trebst; H Hecker; G Berding
Journal:  Gut       Date:  2006-05-08       Impact factor: 23.059

4.  Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study.

Authors:  T Piche; G Vanbiervliet; F Cherikh; Z Antoun; P M Huet; E Gelsi; J-F Demarquay; F-X Caroli-Bosc; S Benzaken; M-C Rigault; C Renou; P Rampal; A Tran
Journal:  Gut       Date:  2005-08       Impact factor: 23.059

5.  Fatigue in multiple sclerosis persists over time: a longitudinal study.

Authors:  N Téllez; J Río; M Tintoré; C Nos; I Galán; X Montalban
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

Review 6.  Hepatitis C virus (HCV) infection: a systemic disease.

Authors:  Antonio Craxì; Giacomo Laffi; Anna Linda Zignego
Journal:  Mol Aspects Med       Date:  2007-11-21

7.  Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

Authors:  Triin Eller; Veiko Vasar; Jakov Shlik; Eduard Maron
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2007-09-26       Impact factor: 5.067

8.  Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

Authors:  J D Fisk; P G Ritvo; L Ross; D A Haase; T J Marrie; W F Schlech
Journal:  Clin Infect Dis       Date:  1994-01       Impact factor: 9.079
  8 in total
  1 in total

1.  Comparison of the effects of amantadine and ondansetron in treatment of fatigue in patients with multiple sclerosis.

Authors:  Mojtaba Khazaei; Ashkan Karevan; Mohammad Taheri; Soudeh Ghafouri-Fard
Journal:  Clin Transl Med       Date:  2019-07-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.